Scripscan:Essen Supplements (India) Ltd
cmp:45
Code:526532
Story:Essen Supplements India Limited engages in the manufacture and sale of construction chemicals and epoxy resins in India. The company is based in Secunderabad, India.Can the share price of a company with virtually no revenues, rally an eye-popping 1100%? It can, in India. From just Rs4.20 on 6 May 2010, the scrip of Essen Supplements India Ltd shot up to Rs45 as on date.The share price has not reacted one bit despite a bear market in India since November last year and despite the fact that the company has reported negligible income for the past five quarters. Similarly, the Secunderabad-based company has hardly made any profits. In March 2010, there was an accumulated loss of Rs6.25 crore. Yet, the share price has been pushing successive highs ever since.This absurd situation is possible only because neither the stock exchange (in this case, the BSE) nor the market regulator bother about rampant price-rigging in Indian markets.
Source:ML
Search This Blog(Over 800 companies covered in the blog).
Archives : Old artciles
Important Disclaimer&Privacy policy
This blog does not share personal information with third parties nor do we store any information about your visit to this blog other than to analyze and optimize your content and reading experience through the use of cookies.You can turn off the use of cookies at anytime by changing your specific browser settings.This privacy policy is subject to change without notice and was last updated on 20.3.2013. If you have any questions, feel free to contact me directly here: arunsharemarket@gmail.com
Investment in equity shares has its own risks.Sincere efforts have been made to present the right investment perspective.The information contained herein is based on analysis and up on sources that I consider reliable. I,however,do not vouch for the accuracy or the completeness thereof.This material is for personal information and am not responsible for any loss incurred based upon it & take no responsibility whatsoever for any financial profits or loss which may arise from the recommendations above.The stock price projections shown are not necessarily indicative of future price performance.The information herein, together with all estimates and forecasts, can change without notice.
